首页> 外文会议>Biosensing and nanomedicine V. >Electrical detection of specific versus non-specific binding events in breast cancer cells
【24h】

Electrical detection of specific versus non-specific binding events in breast cancer cells

机译:电检测乳腺癌细胞中特异性和非特异性结合事件

获取原文
获取原文并翻译 | 示例

摘要

Detection of circulating tumor cells (CTCs) from patient blood samples offers a desirable alternative to invasive tissue biopsies for screening of malignant carcinomas. A rigorous CTC detection method must identify CTCs from millions of other formed elements in blood and distinguish them from healthy tissue cells also present in the blood. CTCs are known to overexpress surface receptors, many of which aid them in invading other tissue, and these provide an avenue for their detection. We have developed carbon nanotube (CNT) thin film devices to specifically detect these receptors in intact cells. The CNT sidewalls are functionalized with antibodies specific to Epithelial Cell Adhesion Molecule (EpCAM), a marker overexpressed by breast and other carcinomas. Specific binding of EpCAM to anti-EpCAM antibodies causes a change in the local charge environment of the CNT surface which produces a characteristic electrical signal. Two cell lines were tested in the device: MCF7, a mammary adenocarcinoma line which overexpresses EpCAM, and MCF10A, a non-tumorigenic mammary epithelial line which does not. Introduction of MCF7s caused significant changes in the electrical conductance of the devices due to specific binding and associated charge environment change near the CNT sidewalls. Introduction of MCF10A displays a different profile due to purely nonspecific interactions. The profile of specific vs. nonspecific interaction signatures using carbon based devices will guide development of this diagnostic tool towards clinical sample volumes with wide variety of markers.© (2012) COPYRIGHT Society of Photo-Optical Instrumentation Engineers (SPIE). Downloading of the abstract is permitted for personal use only.
机译:从患者血液样本中检测循环肿瘤细胞(CTC)为侵入性组织活检提供了一种理想的替代方法,用于筛查恶性癌。严格的CTC检测方法必须从血液中数百万种其他形成的元素中识别CTC,并将它们与血液中也存在的健康组织细胞区分开。众所周知,CTC会过表达表面受体,其中许多受体会帮助它们入侵其他组织,这些为检测它们提供了途径。我们已经开发出碳纳米管(CNT)薄膜设备来特异性检测完整细胞中的这些受体。 CNT侧壁使用上皮细胞粘附分子(EpCAM)特异性抗体进行功能化,EpCAM是乳腺癌和其他癌过度表达的标志物。 EpCAM与抗EpCAM抗体的特异性结合会导致CNT表面局部电荷环境发生变化,从而产生特征性的电信号。在该设备中测试了两种细胞系:MCF7(一种过度表达EpCAM的乳腺腺癌细胞系)和MCF10A(一种非肿瘤形成性的乳腺上皮细胞系,其不过度表达)。由于CNT侧壁附近的特定结合和相关的电荷环境变化,MCF7的引入引起了设备电导率的重大变化。由于纯粹的非特异性相互作用,MCF10A的引入显示出不同的概况。使用基于碳的设备进行的特异性与非特异性相互作用签名的概况将指导该诊断工具向具有多种标记物的临床样品量发展。©(2012)COPYRIGHT光电仪器工程师协会(SPIE)。摘要的下载仅允许个人使用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号